To access this element change to forms mode OFF
Grant Award View - GA30021
Novel Nanotechnology for the Delivery of Amyloid and Tau aggregation...
GA ID:
GA30021
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$472,551.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Novel Nanotechnology for the Delivery of Amyloid and Tau aggregation Targeting siRNA for a potential Alzheimer's Disease Therapy
Purpose:
A key challenge for treating neurodegenerative diseases is delivery of drugs across the blood–brain barrier (BBB). This project will develop advanced BBB “nanoshuttles” based on the role of the GLUT family of transporters to facilitate BBB delivery and specific neuronal uptake to transport nanotherapeutics into brain and target the key protein towards future AD clinical therapy.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1166024
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Macquarie University
Recipient ABN:
90 952 801 237
Grant Recipient Location
Suburb:
Macquarie Park
Town/City:
Macquarie Park
Postcode:
2113
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA